Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity

European Journal of Immunology

Volumn 37, Issue 8, 2007, Pages 2063-2074

  Heit, Antje ^a   Schmitz, Frank ^a   Haas, Tobias ^a   Busch, Dirk H ^a,b   Wagner, Hermann ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Dendritic cells; T cells; Vaccination

Indexed keywords

ANTIGEN; IMIQUIMOD; MICROSPHERE; OLIGODEOXYNUCLEOTIDE; POLYGLACTIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BIODEGRADABILITY; CANCER CELL CULTURE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DELIVERY SYSTEM; ENDOSOME; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; DENDRITIC CELLS; ENDOSOMES; LACTIC ACID; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MICROSPHERES; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; POLYGLYCOLIC ACID; POLYMERS; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; VACCINES, SYNTHETIC;

EID: 34547900682     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737169     Document Type: Article

References (54)

1. Jodar, L, Duclos, P., Milstien, J. B., Griffiths, E., Aguado, M. T. and Clements, C. J., Ensuring vaccine safety in immunization programmes - a WHO perspective. Vaccine 2001. 19: 1594-1605.
2. Ramon, G., Procedres pour acroitre la production des antitoxins. Ann. Institut Pasteur 1926. 40: 1-10.
3. Gupta, R. K., Aluminum compounds as vaccine adjuvants. Adv. Drug Deliv. Rev. 1998. 32: 155-172.
4. Pamer, E. G., Immune responses to Listeria monocyrogenes. Nat. Rev. Immunol. 2004. 4: 812-823.
5. Zammit, D. J., Cauley, L. S., Pham, Q. M. and Lefrancois, L. Dendritic cells maximize the memory CD8T cell response to infection. Immunity 2005. 22: 561-570.
6. Krieg, A. M., CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002. 20: 709-760.
7. Wagner, H., Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol. 1999. 73: 329-368.
8. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
9. Guermonprez, P., Valladeau, J., Zitvogel, L, Thery, C. and Amigorena S., Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002. 20: 621-667.
10. Akira, S. and Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 2004. 4: 499-511.
11. Wagner, H., The immunobiology of the TLR9 subfamily. Trends Immunol. 2004. 25: 381-386.
12. Lee, H. K., Dunzendorfer, S., Soldau, K. and Tobias, P. S., Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 2006. 24: 153-163.
13. Hacker, H., Mischak, H., Hacker, G., Eser, S., Prenzel, N., Ullrich, A. and Wagner, H., Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells. EMBO J. 1999. 18: 6973-6982.
14. Ackerman, A. L., Kyritsis, C., Tampe, R. and Cresswell, P., Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. USA 2003. 100: 12889-12894.
15. Guermonprez, P., Saveanu, L, Kleijmeer, M., Davoust, J., Van Endert, P. and Amigorena, S., EP-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003. 425: 397-402.
16. Cho, H. J., Takabayashi, K., Cheng, P. M., Nguyen, M. D., Corr, M., Tuck, S. and Raz, E., Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat. Biotechnol. 2000. 18: 509-514.
17. Heit, A., Maurer, T., Hochrein, H., Bauer, S., Huster, K. M., Busch, D. H. and Wagner, H., Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells. J. Immunol. 2003. 170; 2802-2805.
18. + T cell responses in nonhuman primates. Proc. Natl. Acad. Sci. USA 2005. 102: 15190-15194.
19. Heit, A., Schmitz, F., O'Keeffe, M, Staib, C., Busch, D. H., Wagner, H. and Huster, K. M., Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines. J. Immunol. 2005. 174: 4373-4380.
20. Wagner, H., Helt, A., Schmitz, F. and Bauer, S., Targeting split vaccines to the endosome improves vaccination. Curr. Opin. Biotechnol. 2004. 15: 538-542.
21. Jiang, W., Gupta, R. K., Deshpande, M. C. and Schwendeman, S. P., Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv. Drug Deliv. Rev. 2005. 57: 391-410.
22. Jilek, S., Ulrich, M., Merkle, H. P. and Walter, E., Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells. Pharm. Res. 2004. 21: 1240-1247.
23. O'Hagan, D. T., Singh, M. and Ulmer, J. B., Microparticles for the delivery of DNA vaccines. Immunol. Rev. 2004. 199: 191-200.
24. O'Hagan, D. T., Singh, M. and Ulmer, J. B., Microparticle-based technologies for vaccines. Methods 2006. 40: 10-19.
25. Westwood, A., Elvin, S. J., Healey, G. D., Williamson, E. D. and Eyles, J. E., Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid). Vaccine 2006. 24: 1736-1743.
26. Diwan, M., Elamanchili, P., Cao, M. and Samuel, J., Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery. Curr. Drug Deliv. 2004. 1: 405-412.
27. Shen, H., Ackerman, A. L., Cody, V., Giodini, A., Hinson, E. R., Cresswell, P., Edelson, R. L. et al., Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 2006. 117: 78-88.
28. Diwan, M., Tafaghodi, M. and Samuel, J., Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres. J. Control Release 2002. 85: 247-262.
29. Schmitz, F., Heit, A., Guggemoos, S., Krug, A., Mages, J., Schiemann, M., Adler, H. et al., Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur. J. Immunol. 2007. 37: 315-327.
30. Sparwasser, T., Vabulas, R. M., Villmow, B., Lipford, G. B. and Wagner, H., Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins. Eur. J. Immunol. 2000. 30: 3591-3597.
31. Busch, D. H., Pilip, I. M., Vijh, S. and Pamer, E. G., Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998. 8: 353-362.
32. Vijh, S. and Pamer, E. G., Immunodominant and subdominant CTL responses to Listeria monocytogenes infection. J. Immunol. 1997. 158: 3366-3371.
33. Audran, R., Peter, K., Dannull, J., Men, Y., Scandella, E., Groettrup, M., Gander, B. and Corradin, G., Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. Vaccine 2003. 21: 1250-1255.
34. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. and Schadendorf, D., Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells. Nat. Med. 1998. 4: 328-332.
35. Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Kelkavoussi, P., Jonuleit, H., Bender, A. et al., Vaccination with mage-3A1 peptide-pulsed mature monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 1999. 190: 1669-1678.
36. Maksimow, M., Miiluniemi, M., Marttila-Ichihara, F., Jalkanen, S. and Hanninen, A., Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity. Blood 2006. 108: 1298-1305.
37. Wilson, N. S., Behrens, G. M., Lundie, R. J., Smith, C. M., Waithman, J., Young, L., Forehan, S. P. et al., Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 2006. 7: 165-172.
38. Inaba, K., Inaba, M., Naito, M. and Steinman, R. M., Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 1993. 178: 479-488.
39. Romero, P., Maryanski, J. L., Corradin, G., Nussenzweig, R. S., Nussenzweig, V. and Zavala, F., Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989. 341: 323-326.
40. Szalay, G., Hess, J. and Kaufmann, S. H., Presentation of Listeria monocytogenes antigens by major histocompatibility complex class I molecules to CD8 cytotoxic T lymphocytes independent of listeriolysin secretion and virulence. Eur. J. Immunol. 1994. 24: 1471-1477
41. Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M, Pack, M. et al., Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 1998. 198: 2163-2173.
42. Ackerman, A. L., Glodini, A. and Cresswell, P., A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 2006. 25: 607-617.
43. Hatsuzawa, K., Tamura, T., Hashimoto, H., Hashimoto, H., Yokoya, S., Miura, M., Nagaya, H. and Wada, I., Involvement of syntaxin 18, an endoplasmic reticulum (ER)-localized SNARE protein, in ER-mediated phagocytosis. Mol. Biol. Cell 2006. 17: 3964-3977.
44. Blander, J. M. and Medzhitov, R., Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006. 440: 808-812.
45. + T cell response. Immunity 2006. 25: 655-664.
46. Diebold, S. S., Kaisho, T., Hammi, H., Akira, S. and Reis e Sousa, C., Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004. 303: 1529-1531.
47. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G. et al., Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004. 303: 1526-1529.
48. Yasuda, K., Rutz, M., Schlatter, B., Metzger, J., Luppa, P. B., Schmitz, F., Haas, T. et al., CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA. Eur. J. Immunol. 2006. 36: 431-436.
49. Zaks, K., Jordan, M., Guth, A., Sellins, K., Kedl, R., Izzo, A., Bosio, C. and Dow, S., Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J. Immunol. 2006. 176: 7335-7345.
50. Langer, R., Drug delivery and targeting. Nature 1998. 392: 5-10.
51. Helt, A., Huster, K. M., Schmitz, F., Schiemann, M., Busch, D. H. and Wagner, H., CpG-DNA aided cross-priming by cross-presenting B cells. J. Immunol. 2004. 172: 1501-1507.
52. Spies, B., Hochrein, H., Vabulas, M., Huster, K., Busch, D. H., Schmitz, F., Heit, A. and Wagner, H., Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J. Immunol. 2003. 171: 5908-5912.
53. Lima, K. M., Santos, S. A., Lima, V. M., Coelho-Castelo, A. A., Rodrigues, J. M., Jr. and Silva, C. L., Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Ther. 2003. 10: 678-685.
54. Ramachandra, L., Sramkoski, R. M., Canaday, D. H., Boom, W. H. and Harding, C. V., Flow analysis of MHC molecules and other membrane proteins in isolated phagosomes. J. Immunol. Methods 1998. 213: 53-71.